Related Experiment Video

Updated: Jun 27, 2026

Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis
07:48

Preparing a 68Ga-labeled Arginine Glycine Aspartate (RGD)-peptide for Angiogenesis

Published on: January 7, 2019

Growth factor/peptide receptor imaging for the development of targeted therapy in oncology

Christophe Van de Wiele1, Hendricus Boersma, Rudi A Dierckx

  • 1Department of Nuclear Medicine, De Pintelaan 185B, 9000 Ghent, Belgium. christophe.vandewiele@ugent.be

Current Pharmaceutical Design
|December 17, 2008
PubMed

Insights

Positron emission tomography (PET) and single photon emission computerized tomography (SPECT) enable non-invasive receptor imaging for cancer drug development. This technique assesses drug delivery, tumor uptake, and metabolism, aiding patient selection for targeted therapies.

Area of Science:

  • Nuclear medicine
  • Radiopharmacology
  • Oncology

Background:

  • Receptor imaging is crucial for developing and applying drugs targeting human malignancy receptors.
  • Positron emission tomography (PET) and single photon emission computerized tomography (SPECT) offer non-invasive assessment of drug behavior in tumors.

Purpose of the Study:

  • To highlight the essential role of PET and SPECT in evaluating receptor-targeting drugs for cancer.
  • To demonstrate how imaging can optimize drug development, assess therapeutic strategies, and guide patient selection for targeted therapies.

Main Methods:

  • Utilizing receptor targeting radiopharmaceuticals with PET and SPECT.
  • Analyzing drug concentration, tumor uptake heterogeneity, clearance rates, and metabolism.
  • Assessing strategies to improve drug penetration and selecting compounds with optimal tumor penetration.

Main Results:

  • Imaging provides critical data on drug-tumor interactions, including concentration and heterogeneity.
  • PET and SPECT facilitate evaluation of drug clearance and metabolism within tumors.
  • These imaging modalities aid in selecting patients likely to benefit from receptor-targeting therapies.

Conclusions:

  • PET and SPECT imaging are indispensable tools for advancing receptor-targeting cancer drug development and clinical application.
  • Imaging enables personalized medicine approaches by identifying suitable candidates for targeted therapies.
  • The data derived from receptor imaging supports optimizing treatment strategies and improving therapeutic outcomes.

More Related Videos

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment10:33

Automated Preparation of [68Ga]Ga-3BP-3940 on a Synthesis Module for PET Imaging of the Tumor Microenvironment

Published on: April 25, 2025

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library07:32

Screening and Identification of Small Peptides Targeting Fibroblast Growth Factor Receptor2 using a Phage Display Peptide Library

Published on: September 30, 2019

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include: